CSL to spin out flu vaccine business, trim workforce in expansive overhaulnews2025-08-19T11:14:52+00:00August 19th, 2025|Endpoints News|
FDA delays decision on Regenxbio’s Hunter syndrome gene therapy by three monthsnews2025-08-18T21:00:56+00:00August 18th, 2025|Endpoints News|
Federal appeals court sends Vanda’s jet lag case back to FDA news2025-08-18T20:00:43+00:00August 18th, 2025|Endpoints News|
How the draft MAHA Commission recommendations may impact pharmanews2025-08-18T19:17:21+00:00August 18th, 2025|Endpoints News|
Genentech ends up to $2B cell therapy collab with Adaptivenews2025-08-18T15:33:05+00:00August 18th, 2025|Endpoints News|
Conflicts among US vaccine advisors declined through 2024, new research showsnews2025-08-18T15:00:37+00:00August 18th, 2025|Endpoints News|
Stealth resubmits ultra-rare disease drug to FDA; Boehringer’s retinal dealnews2025-08-18T14:57:38+00:00August 18th, 2025|Endpoints News|
GoodRx, Novo Nordisk partner to offer discounted GLP-1s at the pharmacy counternews2025-08-18T13:00:59+00:00August 18th, 2025|Endpoints News|
Skyhawk’s RNA mission gets another $2B lift via Merck KGaAnews2025-08-18T12:00:55+00:00August 18th, 2025|Endpoints News|
Updated: Reunion’s psychedelic approach in postpartum depression clears Phase 2 trialnews2025-08-18T11:37:06+00:00August 18th, 2025|Endpoints News|
